<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients who have had <z:hpo ids='HP_0001297'>stroke</z:hpo> are at significant risk for various neuropsychiatric illnesses </plain></SENT>
<SENT sid="1" pm="."><plain>The most common and important of these are poststroke <z:hpo ids='HP_0000716'>depression</z:hpo> and poststroke <z:hpo ids='HP_0000726'>dementia</z:hpo> (attributable to vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, Alzheimer's <z:hpo ids='HP_0000726'>dementia</z:hpo>, or a combination of mechanisms) </plain></SENT>
<SENT sid="2" pm="."><plain>Poststroke neuropathology may lead some patients to experience concurrent and "overlapping" mood and cognitive symptoms </plain></SENT>
<SENT sid="3" pm="."><plain>Less frequently, poststroke <z:hpo ids='HP_0000739'>anxiety</z:hpo> disorders, <z:hpo ids='HP_0000709'>psychosis</z:hpo>, isolated pathologic expressions of emotions, and <z:hpo ids='HP_0000741'>apathy</z:hpo> or <z:mp ids='MP_0002899'>fatigue</z:mp> may be encountered </plain></SENT>
<SENT sid="4" pm="."><plain>The authors review the current literature on poststroke neuropsychiatry and offer an integrated approach to pathophysiologic concepts and clinical surveillance, screening, diagnosis, and evidence-based pharmacologic and nonpharmacologic intervention for these clinical problems on the clinical boundary between neurology and psychiatry </plain></SENT>
</text></document>